Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs

European Journal of Medicinal Chemistry

Volumn 43, Issue 3, 2008, Pages 478-485

  Abraham, Michael H ^a   Ibrahim, Adam ^a   Acree Jr , William E ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Abraham equation; Blood lung; Drugs; Hydrogen bond; Linear free energy relationship; Lung; Partition coefficients; Plasma lung; Volatile organic compounds

Indexed keywords

ERYTHROMYCIN; FENTANYL; FLUOXETINE; HALOPERIDOL; HEXOBARBITAL; HYDROQUINONE; HYDROXYZINE; IMIPRAMINE; INAPERISONE; LIDOCAINE; LORAZEPAM; METHYLPHENIDATE; METOPROLOL; MIDAZOLAM; MILOXACIN; NALIDIXIC ACID; NICOTINE; NITRAZEPAM; OLANZAPINE; OXPRENOLOL; PENICILLIN V; PENTAZOCINE; PHENCYCLIDINE; PHENOBARBITAL; PHENYTOIN; PINDOLOL; PRACTOLOL; TEGAFUR; UNINDEXED DRUG; VOLATILE ORGANIC COMPOUND;

ARTICLE; CONTROLLED STUDY; HUMAN; LUNG FUNCTION; NONHUMAN; PARTITION COEFFICIENT; RAT; SOLVATION; TISSUE DISTRIBUTION;

AIR; ANIMALS; HUMANS; LUNG; ORGANIC CHEMICALS; PROBABILITY; RATS; TISSUE DISTRIBUTION; VOLATILIZATION;

EID: 40049107789     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.04.002     Document Type: Article

References (58)

1. Abraham M.H., and Weathersby P.K. J. Pharm. Sci. 83 (1994) 1450-1455
2. Fiserova-Bergerova V., and Diaz M.L. Int. Arch. Occup. Environ. Health 58 (1986) 75-87
3. Sweeney L.M., Himmelstein M.W., and Gargas M.L. Chem. Biol. Interact. 135-136 (2001) 303-322
4. Filser J.G., Schmidbauer R., Rampf F., Baur C.M., Putz C., and Csanady G.A. Toxicol. Appl. Pharmacol. 169 (2000) 40-51
5. Knaak J.B., Smith L.W., Fitzpatrick R.D., Olson J.R., and Newton P.E. Inhal. Toxicol. 10 (1998) 65-85
6. Csanady Gy.A., Denk B., Putz C., Kreuzer P.E., Kessler W., Baur C., Gargas M.L., and Filser J.G. Toxicol. Appl. Pharmacol. 165 (2000) 1-26
7. Steward A., Allott P.R., Cowles A.L., and Mapleson W.W. Br. J. Anaesth. 45 (1973) 282-293
8. Thrall K.D., Gies R.A., Muniz J., Woodstock A.G., and Higgins G. J. Toxicol. Environ. Health A 65 (2002) 2075-2086
9. Himmelstein M.W., Carpenter S.C., Evans M.V., Hinderliter P.M., and Kenyon E.M. Toxicol. Sci. 79 (2004) 28-37
10. Balaz S., and Luckacova V. Quant. Struct.-Act. Relat. 18 (1999) 361-368
11. Zhang H. J. Pharm. Sci. 93 (2004) 1595-1604
12. Wojcikowski J., and Daniel W.A. Pol. J. Pharmacol. 54 (2002) 647-654
13. Fazio F., Todde S., Moresco R.M., Simonelli P., Baraldi P.G., Cacciari B., Spalluto G., Varani K., Monopoli A., Matarrese M., Carpinelli A., Magni F., and Kienle G.K. J. Med. Chem. 43 (2000) 4359-4362
14. Poulin P., and Theil F.P. J. Pharm. Sci. 89 (2000) 16-35
15. Davila D., and Kolacny-Babic L. Biopharm. Drug Dispos. 12 (1991) 505-514
16. Lee H.S., and Lee M.G. Biopharm. Drug Dispos. 16 (1995) 547-561
17. Javaid J.I., and Davis J.M. Biopharm. Drug Dispos. 14 (1993) 357-364
18. Cruickshank J.M. Am. Heart J. 100 (1980) 160-178
19. Hosseini-Yeganeh M., and McLachlan A.J. J. Pharm. Sci. 90 (2001) 1817-1828
20. Gasco M.R., Fundaro A., Cavalli R., Bargoni A., and Vighetto D. Pharmacol. Res. 4 (2000) 337-343
21. Poulin P., and Theil F.P. J. Pharm. Sci. 91 (2002) 1358-1367
22. Bjorkman S., Wada D.R., Berling B.M., and Benoni G.J. J. Pharm. Sci. 90 (2001) 1226-1241
23. Bjorkman S., Fyge A., and Qi Z. J. Pharm. Sci. 85 (1996) 887-889
24. Bjorkman S. J. Pharm. Pharmacol. 54 (2002) 1237-1245
25. Blakey G.E., Nestorov I.A., Arundel P.A., Aarons L.J., and Rowland M.J. J. Pharmacokinet. Biopharm. 25 (1997) 277-312
26. Corley R.A., English J.C., Hill T.S., Fiorcia L.A., and Morgott D.A. Toxicol. Appl. Pharmacol. 165 (2000) 163-174
27. Schillings R.T., Sisenwine S.F., and Ruelius H.W. Drug Metab. Dispos. 5 (1977) 425-435
28. Aravagiri M., Teper Y., and Marder S.R. Biopharm. Drug Dispos. 20 (1999) 369-377
29. Han K.S., Kim Y.G., Yoo J.K., Lee J.W., and Lee M.G. Biopharm. Drug Dispos. 19 (1998) 493-500
30. Haddad S., Withey J., Lapare S., Law F., and Krishnan K. Environ. Toxicol. Pharmacol. 5 (1998) 245-255
31. Bonate P.L., Swann A., and Silverman P.B. J. Pharm. Sci. 85 (1996) 878-883
32. Doze P., Elsinga P.H., Maas B., Van Waarde A., Wegman T., and Vaalburg W. Neurochem. Int. 40 (2002) 145-155
33. Zhang H., and Zhang Y. J. Med. Chem. 49 (2006) 5815-5829
34. Rodgers T., Leahy D., and Rowland M. J. Pharm. Sci. 94 (2005) 1237-1248
35. Rodgers T., Leahy D., and Rowland M. J. Pharm. Sci. 94 (2005) 1259-1275
36. Rodgers T., and Rowland M. J. Pharm. Sci. 95 (2006) 1238-1257
37. Black K.A., and Finch L. Toxicol. Lett. 78 (1995) 73-78
38. Banks W.R., Yamakitra H., and Digenis G.A. J. Pharm. Sci. 81 (1992) 797-801
39. van den Bosch J.M.M., Westerman C.J.J., Aumann J., Edsbacker S., Tonnesson M., and Selroos O. Biopharm. Drug Dispos. 14 (1993) 455-459
40. Nagaraja N.V., Singh S.K., Paliwal J.K., and Gupta R.C. J. Pharm. Pharmacol. 52 (2000) 1257-1264
41. Pong S.F., and Huang C.L. J. Pharm. Sci. 63 (1974) 1527-1532
42. Schmalzing G. Drug. Metab. Dispos. 5 (1977) 104-115
43. Kotaki H., Nakazato F., Aoyama T., Saitoh Y., and Nakagawa F. Chem. Pharm. Bull. 36 (1988) 3190-3195
44. Abraham M.H., Ibrahim A., and Acree Jr. W.E. Chem. Res. Toxicol. 18 (2005) 904-911
45. Abraham M.H., Ibrahim A., and Acree Jr. W.E. Eur. J. Med. Chem. 41 (2006) 494-502
46. Abraham M.H., Ibrahim A., Zhao Y.H., and Acree Jr. W.E. J. Pharm. Sci. 95 (2006) 2091-2100
47. Abraham M.H., Ibrahim A., and Acree Jr. W.E. Chem. Res. Toxicol. 19 (2006) 801-808
48. Abraham M.H., and Ibrahim A. Eur. J. Med. Chem. 41 (2006) 1430-1438
49. M.H. Abraham, A. Ibrahim, W.E. Acree Jr., Eur. J. Med. Chem., in press.
50. Abraham M.H. Chem. Soc. Revs. 22 (1993) 73-83
51. Abraham M.H., Ibrahim A., and Zissimos A.M. J. Chromatogr., A 1037 (2004) 29-47
52. Kennard R.W., and Stone L.A. Technometrics 11 (1959) 137-148
53. Liu H.X., Yao X.J., Zhang R.S., Liu M.C., Hu Z.D., and Fan B.T. J. Comput. Aided Mol. Des. 19 (2005) 499-508
54. Pharma Algorithms. ADME Boxes, Version 3.0 (2006), PharmaAlgorithms Inc, 591 Indian Road, Toronto, ON M6P 2C4, Canada
55. Abraham M.H., Ibrahim A., and Acree Jr. W.E. Fluid Phase Eq. 251 (2007) 93-109
56. Abraham M.H. Can we identify models for intestinal absorption, blood-brain barrier distribution and intestinal absorption?. In: Ford M., Livingstone D., Dearden J., and van de Waterbeemd H. (Eds). EuroQSAR 2002. Designing Drugs and Crop Protectants: Processes, Problems and Solutions (2003), Blackwell, Oxford 5-7
57. Abraham M.H., and Martins F. J. Pharm. Sci. 93 (2004) 1508-1523
58. Minitab, Version 14 (2003), Minitab Inc, Quality Plaza, 1829 Pine Hall road, State College, Pa 16801-3008, USA